INDIA – The Novo Nordisk Education Foundation (NNEF) has launched a Centre for Excellence (CoE) for children with type 1 diabetes in collaboration with the Government Institute of Medical Sciences (GIMS) in Greater Noida, India.
Diabetes affects 74.2 million people in India. According to the most recent estimates, the country has over 229,000 people under the age of 20 who have Type 1 diabetes.
Dr (Brig) Rakesh Gupta, Director, Government Institute of Medical Sciences, Greater Noida, said, “India has the highest estimated number of prevalent Type 1 diabetes cases in people under 20 years of age.
Access to the right care is crucial and we are pleased to have found a partner in the Novo Nordisk Education Foundation.”
Because the population of people living with Type 1 diabetes is so small in comparison to those living with Type 2 diabetes, the former may not receive the attention it deserves, resulting in serious health consequences for children with the condition.
The Novo Nordisk Education Foundation’s access to diabetes care strategy includes the Centre of Excellence (CoE).
The newly inaugurated Center of Excellence (CoE) will help improve the quality of care for type 1 diabetes and ensure availability of insulin supply to children with type 1 diabetes in the greater Noida region.
Underprivileged children with type 1 diabetes in India may not have consistent access to insulin for treatment, resulting in debilitating health consequences.
This CoE aims to provide free care for these children while also advocating with the government for improved and long-term access to insulin supplies.
It will also provide assistance, education, and quality training in order to create a pool of resource personnel for the management of childhood diabetes.
Further, it will contribute to the creation of a registry and promote research and development (R&D) to encourage the generation of scientific publications and provide appropriate recommendations for the management of diabetes mellitus in Indian children.
The strategy aims to improve the health and quality of life of children with Type 1 diabetes by strengthening the healthcare system’s capacity to diagnose and treat Type 1 diabetes in children.
It will also achieve its objective through driving advocacy to get policymakers’ attention to care, and sharing learnings through periodic articles.
So far, the Novo Nordisk Education Foundation has improved access to better care for over 6,000 children with Type 1 diabetes across the country through initiatives like these.
Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE
